Lafayette, CA, United States of America

Richard Horuk


Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Belmont, CA (US) (2001 - 2002)
  • Lafayette, CA (US) (2003 - 2007)

Company Filing History:


Years Active: 2001-2007

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Richard Horuk: Innovator in Anti-Inflammatory Agents

Introduction

Richard Horuk is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 13 patents to his name, Horuk's work has had a meaningful impact on medical treatments.

Latest Patents

Horuk's latest patents focus on piperazine derivatives and their use as anti-inflammatory agents. One of his inventions is directed to acyl piperazine derivatives, which are useful in treating inflammatory disorders in humans. This invention also includes pharmaceutical compositions containing these compounds and methods for their application. Another patent similarly addresses acyl piperazine derivatives, detailing their formula and potential as anti-inflammatory agents. These innovations highlight Horuk's commitment to advancing medical science and improving patient care.

Career Highlights

Throughout his career, Richard Horuk has worked with prominent companies, including Schering Aktiengesellschaft. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of anti-inflammatory treatments.

Collaborations

Horuk has collaborated with notable professionals in his field, including Joseph E. Hesselgesser and John G. Bauman. These partnerships have likely contributed to the success of his inventions and the development of effective pharmaceutical solutions.

Conclusion

Richard Horuk's contributions to the field of anti-inflammatory agents through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the pharmaceutical industry and offers hope for better treatment options for patients suffering from inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…